Our Experts

Heather Roulston

Manager, Market Research

Expertise: Payer Market Research, Industry Trends, Policy and Regulation

Heather Roulston is a market research manager at MMIT, with 14 years of experience across several departments. With her deep industry knowledge and collaborative approach, Heather provides in-depth market insights to both internal and external clients. Prior to joining MMIT, she worked as a senior analytics chemist at several leading pharmaceutical companies, where she honed her analytical expertise and passion for data-driven decision-making.

⟨ Back to Our Experts

Insights by Heather Roulston

Article | December 18, 2025

Copay Accumulators and Maximizers, Part 2: Implications for Pharma

Copay accumulator and maximizer programs are now firmly embedded in the commercial market, and their influence on patient access and manufacturer strategy is becoming impossible to overlook. In the first installment of our two-part series on copay accumulators and maximizers, we shared recent Indices research on how payers are deploying and measuring these programs.

Article | December 11, 2025

Inside the Payer Playbook: Copay Accumulators and Maximizers, Part 1

As payers continue to refine their cost-containment strategies, copay accumulator and copay maximizer programs have quietly become standard tools in their playbook. As of March 2025, 21 states have enacted laws banning payer/PBM use of copay accumulator programs for state-regulated health plans, including the individual, fully insured large-group, and small-group markets.

Article | October 9, 2025

The Cost of Reform: What Payers Expect from the One Big Beautiful Bill Act

In July 2025, the 2025 Federal Budget Reconciliation bill, known colloquially as the One Big Beautiful Bill Act (OBBBA) and officially as H.R.1, was signed into law.

Article | August 7, 2025

Impact of the New Administration on Vaccine Policy and Access

Manufacturers should be prepared for a period of uncertainty and potential disruption in vaccine policy. The recent overhaul of the CDC’s Advisory Committee on Immunization Practices (ACIP) signals a shift that could affect vaccine recommendations, public trust, and payer coverage decisions.

Article | April 13, 2023

Key Trends in Medical Benefit Contracting

The rising cost of specialty pharmaceuticals has motivated payers to implement tighter restrictions and seek both traditional and value-based contracts. As manufacturers are already contracting with GPOs, distribution networks and medical practices, most would prefer to avoid contracting with payers and PBMs for their medical benefit products.

Real-World Data Solutions

Payer Data Intelligence Solutions

Payer and Provider Insights Solutions

Payer and Specialty Pharmacy Solutions

Promotional Solutions

Market Access

Patient Journey

Brand Performance and Strategy

Contracting and Reimbursement